# MGAT5

## Overview
MGAT5 is a gene that encodes the enzyme alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase, commonly referred to as N-acetylglucosaminyltransferase-V (GnT-V). This enzyme is a type II membrane protein that plays a pivotal role in the N-glycosylation pathway, specifically in the branching of N-glycans within the Golgi apparatus. The enzyme's activity is crucial for various cellular processes, including protein folding, stability, and cell signaling, by adding N-acetylglucosamine to mannose residues on glycoproteins (Hirata2022Shedding; Abdel2014Golgi). MGAT5 is involved in modulating immune responses and cellular interactions, impacting processes such as nutrient uptake, cell proliferation, and migration. Its dysregulation is associated with pathological conditions, including cancer progression and autoimmune diseases, highlighting its significance in both normal physiology and disease states (Granovsky2000Suppression; Demetriou2001Negative).

## Structure
The MGAT5 gene encodes the enzyme N-acetylglucosaminyltransferase-V (GnT-V), a type II membrane protein consisting of 741 amino acids. The primary structure of MGAT5 includes a sequence that facilitates its role in N-glycan branching (Nagae2018Structure). The secondary structure features a GT-B fold, characterized by two Rossmann folds, which is distinct from other mammalian GlcNAc transferases that typically have GT-A folds (Nagae2018Structure). The tertiary structure of GnT-V reveals a cross-like shape composed of four subdomains: N-terminal, two middle domains, and a C-terminal domain, with the luminal domain determined at 1.9 Å resolution (Nagae2018Structure). This structure is stabilized by eight disulfide bonds, contributing to its stability and function (Nagae2018Structure).

The enzyme's catalytic center is located in a large cleft between the two Rossmann fold domains, with specific residues such as E297 playing a crucial role in its catalytic mechanism (Nagae20203D). The N-terminal helical domain is involved in subcellular localization rather than catalysis (Nagae20203D). Post-translational modifications, including glycosylation, are present, with three N-glycans identified, although only one is assigned in the crystal structure (Nagae2018Structure).

## Function
MGAT5 encodes an enzyme that plays a crucial role in the N-glycosylation pathway, specifically by adding N-acetylglucosamine to mannose residues on glycoproteins. This modification is essential for protein folding, stability, and cell signaling. MGAT5 is active in the Golgi apparatus, where it contributes to the formation of complex N-glycans, which are important for various cellular processes (Hirata2022Shedding; Abdel2014Golgi).

In healthy human cells, MGAT5 is involved in promoting nutrient uptake and metabolism. It enhances the surface residency of glucose transporters, which is crucial for glucose uptake, and increases amino acid uptake, particularly under nutrient-limiting conditions (Abdel2014Golgi). MGAT5 also plays a role in regulating osteogenic differentiation of bone marrow mesenchymal stem cells by modulating signaling pathways such as Wnt/β-catenin and BMP/TGF-β, which are vital for bone formation and health (Liu2023Loss).

MGAT5-modified glycans are involved in the negative regulation of T-cell activation, impacting immune response modulation. These glycans form a lattice with galectins, which restricts T-cell receptor clustering and signaling, thereby maintaining immune tolerance and preventing autoimmunity (Demetriou2001Negative).

## Clinical Significance
Alterations in the MGAT5 gene, which encodes the enzyme β1,6 N-acetylglucosaminyltransferase V, have significant clinical implications in both cancer and autoimmune diseases. In cancer, MGAT5 is associated with tumor progression and metastasis. The enzyme catalyzes the formation of β1,6 GlcNAc linkages on N-glycans, which are often upregulated in malignancies. These modifications enhance cell motility and invasion by affecting integrin receptors and focal adhesion turnover, crucial for tumor growth and metastasis (Granovsky2000Suppression; Taniguchi2021True). MGAT5 products also stimulate oncogene signaling pathways, such as the PI3K/Akt pathway, contributing to cancer progression (Granovsky2000Suppression).

In autoimmune diseases, MGAT5 plays a role in regulating T-cell activation. Deficiency in MGAT5 leads to enhanced T-cell receptor (TCR) clustering and signal transduction, lowering the activation threshold and increasing susceptibility to autoimmune conditions like multiple sclerosis (Demetriou2001Negative). MGAT5-modified glycans are crucial for maintaining immune tolerance by limiting TCR clustering through interactions with galectins (Demetriou2001Negative). Alterations in MGAT5 expression or function can thus impact immune responses, contributing to the development of autoimmune diseases (Huffman2011Polymorphisms).

## Interactions
MGAT5, also known as alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase, is involved in the modification of N-glycans on glycoproteins. It plays a significant role in cell signaling and adhesion by interacting with various proteins. However, MGAT5 does not form complexes with other N-acetylglucosaminyltransferases (MGATs) or with Golgi alpha-mannosidase IIX (MAN2A2), suggesting it may function independently in glycan processing (KhoderAgha2019Nacetylglucosaminyltransferases). 

Despite its lack of interaction with other MGATs, MGAT5 is known to influence cellular processes through its role in glycosylation. It enhances the surface retention of receptors, thereby increasing cellular sensitivity to growth cues and cytokines, which is crucial for processes like cell proliferation and migration (Cheung2007Mgat5). MGAT5's activity is also linked to the regulation of PI3K/Akt signaling pathways, where it interacts with the tumor suppressor PTEN to modulate cell growth and polarity (Cheung2007Mgat5). These interactions highlight MGAT5's role in enhancing growth signaling and its potential impact on cancer progression.


## References


[1. (Nagae2018Structure) Masamichi Nagae, Yasuhiko Kizuka, Emiko Mihara, Yu Kitago, Shinya Hanashima, Yukishige Ito, Junichi Takagi, Naoyuki Taniguchi, and Yoshiki Yamaguchi. Structure and mechanism of cancer-associated n-acetylglucosaminyltransferase-v. Nature Communications, August 2018. URL: http://dx.doi.org/10.1038/s41467-018-05931-w, doi:10.1038/s41467-018-05931-w. This article has 60 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-018-05931-w)

[2. (Granovsky2000Suppression) Maria Granovsky, Jimmie Fata, Judy Pawling, William J. Muller, Rama Khokha, and James W. Dennis. Suppression of tumor growth and metastasis in mgat5-deficient mice. Nature Medicine, 6(3):306–312, March 2000. URL: http://dx.doi.org/10.1038/73163, doi:10.1038/73163. This article has 461 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/73163)

[3. (Cheung2007Mgat5) Pam Cheung and James W. Dennis. Mgat5 and pten interact to regulate cell growth and polarity. Glycobiology, 17(7):767–773, March 2007. URL: http://dx.doi.org/10.1093/glycob/cwm037, doi:10.1093/glycob/cwm037. This article has 35 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/glycob/cwm037)

[4. (KhoderAgha2019Nacetylglucosaminyltransferases) Fawzi Khoder-Agha, Paulina Sosicka, Maria Escriva Conde, Antti Hassinen, Tuomo Glumoff, Mariusz Olczak, and Sakari Kellokumpu. N-acetylglucosaminyltransferases and nucleotide sugar transporters form multi-enzyme–multi-transporter assemblies in golgi membranes in vivo. Cellular and Molecular Life Sciences, 76(9):1821–1832, February 2019. URL: http://dx.doi.org/10.1007/s00018-019-03032-5, doi:10.1007/s00018-019-03032-5. This article has 39 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-019-03032-5)

[5. (Hirata2022Shedding) Tetsuya Hirata, Misaki Takata, Yuko Tokoro, Miyako Nakano, and Yasuhiko Kizuka. Shedding of n-acetylglucosaminyltransferase-v is regulated by maturity of cellular n-glycan. Communications Biology, August 2022. URL: http://dx.doi.org/10.1038/s42003-022-03697-y, doi:10.1038/s42003-022-03697-y. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s42003-022-03697-y)

[6. (Demetriou2001Negative) Michael Demetriou, Maria Granovsky, Sue Quaggin, and James W. Dennis. Negative regulation of t-cell activation and autoimmunity by mgat5 n-glycosylation. Nature, 409(6821):733–739, February 2001. URL: http://dx.doi.org/10.1038/35055582, doi:10.1038/35055582. This article has 717 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/35055582)

[7. (Abdel2014Golgi) Anas M Abdel Rahman, Michael Ryczko, Miyako Nakano, Judy Pawling, Tania Rodrigues, Anita Johswich, Naoyuki Taniguchi, and James W Dennis. Golgi n-glycan branching n-acetylglucosaminyltransferases i, v and vi promote nutrient uptake and metabolism. Glycobiology, 25(2):225–240, October 2014. URL: http://dx.doi.org/10.1093/glycob/cwu105, doi:10.1093/glycob/cwu105. This article has 40 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/glycob/cwu105)

[8. (Liu2023Loss) Xiao-Po Liu, Jia-Qi Li, Ruo-Yu Li, Guo-Long Cao, Yun-Bo Feng, and Wei Zhang. Loss of n-acetylglucosaminyl transferase v is involved in the impaired osteogenic differentiation of bone marrow mesenchymal stem cells. Experimental Animals, 72(3):413–424, 2023. URL: http://dx.doi.org/10.1538/expanim.22-0129, doi:10.1538/expanim.22-0129. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1538/expanim.22-0129)

[9. (Huffman2011Polymorphisms) Jennifer E. Huffman, Ana Knežević, Veronique Vitart, Jayesh Kattla, Barbara Adamczyk, Mislav Novokmet, Wilmar Igl, Maja Pučić, Lina Zgaga, Åsa Johannson, Irma Redžić, Olga Gornik, Tatijana Zemunik, Ozren Polašek, Ivana Kolčić, Marina Pehlić, Carolien A.M. Koeleman, Susan Campbell, Sarah H. Wild, Nicholas D. Hastie, Harry Campbell, Ulf Gyllensten, Manfred Wuhrer, James F. Wilson, Caroline Hayward, Igor Rudan, Pauline M. Rudd, Alan F. Wright, and Gordan Lauc. Polymorphisms in b3gat1, slc9a9 and mgat5 are associated with variation within the human plasma n-glycome of 3533 european adults. Human Molecular Genetics, 20(24):5000–5011, September 2011. URL: http://dx.doi.org/10.1093/hmg/ddr414, doi:10.1093/hmg/ddr414. This article has 75 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddr414)

[10. (Nagae20203D) Masamichi Nagae, Yoshiki Yamaguchi, Naoyuki Taniguchi, and Yasuhiko Kizuka. 3d structure and function of glycosyltransferases involved in n-glycan maturation. International Journal of Molecular Sciences, 21(2):437, January 2020. URL: http://dx.doi.org/10.3390/ijms21020437, doi:10.3390/ijms21020437. This article has 51 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21020437)

[11. (Taniguchi2021True) Naoyuki Taniguchi, Yuki Ohkawa, Kento Maeda, Yoichiro Harada, Masamichi Nagae, Yasuhiko Kizuka, Hideyuki Ihara, and Yoshitaka Ikeda. True significance of n-acetylglucosaminyltransferases gnt-iii, v and α1,6 fucosyltransferase in epithelial-mesenchymal transition and cancer. Molecular Aspects of Medicine, 79:100905, June 2021. URL: http://dx.doi.org/10.1016/j.mam.2020.100905, doi:10.1016/j.mam.2020.100905. This article has 28 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.mam.2020.100905)